Quest Diagnostics Incorporated (DGX)

Quest Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	686	315	872	1,158	1,192
Cash & Cash Equivalents	686	315	872	1,158	1,192
Cash Growth	117.78%	-63.88%	-24.70%	-2.85%	782.96%
Receivables	1,210	1,195	1,438	1,520	1,063
Inventory	190	192	208	223	123
Other Current Assets	286	196	223	157	112
Total Current Assets	2,372	1,898	2,741	3,058	2,490
Property, Plant & Equipment	2,418	2,351	2,304	2,231	1,971
Long-Term Investments	135	132	141	521	482
Goodwill and Intangibles	8,899	8,312	8,262	8,040	7,740
Other Long-Term Assets	198	144	163	176	160
Total Long-Term Assets	11,650	10,939	10,870	10,968	10,353
Total Assets	14,022	12,837	13,611	14,026	12,843
Accounts Payable	1,359	1,396	1,600	1,633	1,041
Current Debt	456	155	153	143	949
Total Current Liabilities	1,815	1,551	1,753	1,776	1,990
Long-Term Debt	4,913	4,467	4,504	4,512	4,379
Other Long-Term Liabilities	952	889	871	929	787
Total Long-Term Liabilities	5,865	5,356	5,375	5,441	5,166
Total Liabilities	7,680	6,907	7,128	7,217	7,156
Total Debt	5,369	4,622	4,657	4,655	5,328
Debt Growth	16.16%	-0.75%	0.04%	-12.63%	36.86%
Retained Earnings	8,825	8,290	7,649	9,303	8,174
Comprehensive Income	-14	-21	-14	-21	-39
Shareholders' Equity	6,307	5,893	6,444	6,759	5,641
Net Cash / Debt	-4,683	-4,307	-3,785	-3,497	-4,136
Working Capital	557	347	988	1,282	500
Book Value Per Share	56.09	51.74	52.53	50.15	41.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).